Publications by authors named "Prakash Vishnu"

Claim this Profile
H
Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome: Current Evidence and Controversies in Clinical Practice.
Prakash Vishnu, David M Aboulafia

Clin Lab Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Extended Half-Life Products, Nonfactor Replacement Therapies, and Gene Therpy for the Treatment of Hemophilia.
Prakash Vishnu, David M Aboulafia

Clin Lab Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort.
Henning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Prakash Vishnu

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamic range of immunoassays for heparin-induced thrombocytopenia.
Henning Nilius, Samra Naas, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Prakash Vishnu

J Thromb Haemost· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.
Henning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, Jan-Dirk Studt, Dimitrios A Tsakiris, Prakash Vishnu

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Diagnosing Heparin-Induced Thrombocytopenia.
Emil List Larsen, Henning Nilius, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Prakash Vishnu

JAMA Netw Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study.
Angelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Prakash Vishnu

J Thromb Haemost· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Henning Nilius, Adam Cuker, Sigve Haug, Christos Nakas, Jan-Dirk Studt, Prakash Vishnu

EClinicalMedicine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic Acid Does Not Retard Bone Union: A Randomized Controlled Trial in Fragility Intertrochanteric Femur Fractures.
Ankit Gulia, Shakti Prasad Das, Suhas Sondur, Preethiv Rajendran, Anwesit Mohanty, Vishnu Prakash

Cureus· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccination associated severe immune thrombocytopenia.
Syed Raza Ali Shah, Sherpa Dolkar, Jacob Mathew, Prakash Vishnu

Exp Hematol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee.
Prakash Vishnu, Joanne Duncan, Nathan Connell, Nichola Cooper, Wendy Lim

J Thromb Haemost· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors.
Lynn M Rose, Hannah A DeBerg, Prakash Vishnu, Jason K Frankel, Adarsh B Manjunath

Front Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Analysis of R-CHOP Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features.
Bhagirathbhai Dholaria, Yenny Alejandra Moreno Vanegas, Nancy Diehl, Aaron C Spaulding, Sue Visscher, Prakash Vishnu

Clin Hematol Int· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.
Donald M Arnold, Nancy M Heddle, Richard J Cook, Cyrus Hsia, Mark Blostein, Prakash Vishnu

Lancet Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Neutrophil-Lymphocyte Ratio is Predictive of Poor Outcomes Following Aneurysmal Subarachnoid Hemorrhage.
Sheheryar A Jamali, Marion T Turnbull, Takahisa Kanekiyo, Prakash Vishnu, Abba C Zubair

J Stroke Cerebrovasc Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care.
Vivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, Taimur Sher, Vivek Roy, Prakash Vishnu

JCO Oncol Pract· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.
Robert D McBane, Waldemar E Wysokinski, Jennifer G Le-Rademacher, Tyler Zemla, Aneel Ashrani, Prakash Vishnu

J Thromb Haemost· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Initiative in Clinical Practice: A Single-Institution Appraisal of Quality Metrics in the Management of Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Alina M Bischin, Prakash Vishnu, Ruqin Chen, Kevin B Knopf, David M Aboulafia

Mayo Clin Proc Innov Qual Outcomes· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia.
Mansour Alfayez, Guillaume Richard-Carpentier, Elias Jabbour, Prakash Vishnu, Kiran Naqvi

Br J Haematol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?
William A Hammond, Prakash Vishnu, Elisa M Rodriguez, Zhuo Li, Bhagirathbhai Dholaria

Mayo Clin Proc· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
Ryan B Sinit, Dick G Hwang, Prakash Vishnu, Jess F Peterson, David M Aboulafia

BMC Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
Sikander Ailawadhi, Abdel-Ghani Azzouqa, David Hodge, Jordan Cochuyt, Prachi Jani, Prakash Vishnu

Clin Lymphoma Myeloma Leuk· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
Vivek Kumar, Sikander Ailawadhi, Leyla Bojanini, Aditya Mehta, Suman Biswas, Prakash Vishnu

Blood Cancer J· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiologies of Extreme Thrombocytosis: A Contemporary Series.
Ronan W Hsieh, Aishwarya Ravindran, Christopher C Hook, Kebede H Begna, Aneel A Ashrani, Prakash Vishnu

Mayo Clin Proc· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography.
Hassan M Ghoz, Paul T Kröner, Fernando F Stancampiano, Andrew W Bowman, Prakash Vishnu

Quant Imaging Med Surg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis